← Leaderboards
Kamrul M Hasan
Charles R. Drew University Of Med & Sci
$719,500
Attributed
$719,500
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $144.5K · FY2019–25$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$719,500 · 2
By mechanism
SC2$430,500 · 1
R16$289,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Insulin Sensitivity”
- Barbara Halina Braffett · George Washington University$18,911,347
- Ionut Bebu · George Washington University$18,911,347
- Petter Bjornstad · University Of Colorado Denver$6,680,527
- Pankaj Arora · University Of Alabama At Birmingham$5,870,690
- Courtney Marie Peterson · University Of Alabama At Birmingham$4,655,471
- Akhilesh Basi Reddy · University Of Pennsylvania$3,892,292
Research focus
Insulin SensitivityMediatingGrantInsulin ResistanceLipid MetabolismMdm2 GeneFatty LiverGenesHepaticInsulinIn VivoKnock-DownLiverLiver DiseasesCellsFatty Acid Glycerol EstersCell ModelFoundationsDiabetes MellitusCardiovascular DiseasesHepatocyteHomeostasisIn VitroMember
Grant awards (5)
Impact of inverse relationship between TP53 and CARF on the development of hepatic steatosis and insulin resistance$144,500
R16 · FY2025 · GM · contact PI
Impact of inverse relationship between TP53 and CARF on the development of hepatic steatosis and insulin resistance$144,500
R16 · FY2024 · GM · contact PI
Role of CARF in Insulin Resistance and Non Alcoholic Fatty Liver disease NAFLD$143,500
SC2 · FY2021 · GM · contact PI
Role of CARF in Insulin Resistance and Non Alcoholic Fatty Liver disease NAFLD$143,500
SC2 · FY2020 · GM · contact PI
Role of CARF in Insulin Resistance and Non Alcoholic Fatty Liver disease NAFLD$143,500
SC2 · FY2019 · GM · contact PI